Chitosan-based microneedle arrays for dermal delivery of Centella asiatica

Int J Pharm. 2022 Nov 5:627:122221. doi: 10.1016/j.ijpharm.2022.122221. Epub 2022 Sep 23.

Abstract

Centella asiatica, a medicinal herb used for wound healing, has a limited effect when delivered as an ointment. Centella asiatica's active component asiatic acid (AA) increases extracellular matrix development and reduces inflammation but cannot penetrate the stratum corneum to access deeper skin layers. To bypass the stratum corneum, we formulated two types of AA-loaded microneedle arrays. We fabricated, characterised and optimised a dissolving array made from chitosan and PVA and a hydrogel array made from chitosan and PVP. Both needles were strong and long enough to pierce the epidermis without breaking. Both were biocompatible with keratinocytes and fibroblasts (>75% viability at 100% concentration) and showed a sustained drug release over 48 h. The hydrogel microneedle released more AA (52.2%) than the dissolving formulation (26.4%); thus, we evaluated them in an excisional rat model. The hydrogel microneedle arrays significantly increased the rate of wound closure compared to the control. This research has shown that the chitosan-PVA hydrogel microneedles could penetrate the epidermis, effectively release AA, and increase the wound closure rate. This AA-loaded delivery system shows promise as a natural treatment for wound healing and may be applied to other bioactive compounds with similar physiochemical properties in the future.

Keywords: Asiatic acid; Chitosan; Dissolving microneedles; Hydrogel microneedles; Topical dermal delivery; Wound healing.

MeSH terms

  • Administration, Cutaneous
  • Animals
  • Centella*
  • Chitosan*
  • Drug Delivery Systems
  • Hydrogels
  • Microinjections
  • Needles
  • Ointments
  • Rats
  • Skin

Substances

  • Chitosan
  • Ointments
  • Centella asiatica extract
  • Hydrogels